OakChart

Firefly Neuroscience Inc

AIFFTechnology·Software - Application·USA·Nano·NASD·Nov 11 • 2:09 PM ET

1.03+0.06 (6.00%)
2026-11-11 20:13 CET
Market cap
15.32 USD m
Revenue, TTM
2.06 USD m
Net income, TTM
-8.28 USD m
Free cash flow, TTM
-6.83 USD m
EPS diluted, TTM
-0.49
P/E
-
Compare

Price

AIFF against its 20, 50 and 200-day averages
2050200
1.001.502.0071.9M143.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26AIFFclose 1.0420-day 1.0050-day 1.14200-day 1.371.04

67.1% under the 52-week high of 3.15 on 26 Mar 2026. 52-week low 0.62 on 23 Feb 2026. Last 15 sessions, 24.4% high to low

Profile

AIFF
52-week range, 16% of the way up
0.623.15

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company, which engages in developing neuroscientific solutions for mental illnesses and neurological disorders. It offers Brain Network Analytics (BNA) platform, a software as a medical solution for the diagnostic and treatment methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. The company was founded in 1979 and is headquartered in Kenmore, NY.

Employees17
IPOApr 06, 1994
Beta0.47
ATR, 14d0.09
Rel volume0.03
Short float3.89%
Insider own9.23%
Inst own10.27%

Snapshot

6 groups

Valuation

Index-
Market Cap16.24M
Enterprise Value8.22M
Income-8.28M
Sales2.06M
Book/sh0.85
Cash/sh0.51
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees17
IPOApr 06, 1994

Ratios

P/E-
Forward P/E-
PEG-
P/S7.88
P/B1.21
P/C2.02
P/FCF-
EV/EBITDA-
EV/Sales3.99
Quick Ratio4.45
Current Ratio4.48
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.49
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y59.70% -
Sales past 3/5Y-53.03% -39.34%
EPS Y/Y TTM80.71%
Sales Y/Y TTM162.84%
EPS Q/Q64.91%
Sales Q/Q66.75%
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own9.23%
Insider Trans0.00%
Inst Own10.27%
Inst Trans3.22%
ROA-59.42%
ROE-71.70%
ROIC-61.63%
Gross Margin54.86%
Oper. Margin-385.23%
Profit Margin-402.14%
SMA203.62%
SMA50-9.25%
SMA200-24.23%
Trades-

Technical

Shs Outstand15.75M
Shs Float14.24M
Short Float3.89%
Short Ratio0.21
Short Interest0.55M
52W High3.15 -67.14%
52W Low0.62 67.61%
Volatility7.92% 7.64%
ATR (14)0.09
RSI (14)49.11
Beta0.47
Rel Volume0.03
Avg Volume2.62M
Volume54,102

Performance

Perf Week-0.48%
Perf Month-6.76%
Perf Quarter-10.78%
Perf Half Y-42.50%
Perf YTD18.29%
Perf Year-37.27%
Perf 3Y-73.05%
Perf 5Y-98.89%
Perf 10Y-77.02%
Recom-
Target Price-
Prev Close0.98
Price1.03
Change %6.00%

Peers

Mkt cap
TickerCompanyMkt cap
CBLLCeribell Inc1.07B
STIMNeuronetics Inc132.52M
NMTCNeuroOne Medical Technologies Corp6.84M
BWAYBrainsway Ltd ADR444.79M
ECORElectroCore Inc73.80M
NPCENeuroPace Inc427.96M
HSCSHeartSciences Inc11.78M
WLDSWearable Devices Ltd3.76M
NXLNexalin Technology Inc1.80M
CLPTClearPoint Neuro Inc290.42M

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 200
  • Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform (GlobeNewswire) +6.33%
  • Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD (GlobeNewswire) +68.91%
  • Firefly Neuroscience's Evoke Platform Selected to Bring Objective Brain-Function Insights to Radial's AI-Native Operating System for Brain Medicine (GlobeNewswire) +37.62%
  • Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes (GlobeNewswire)
  • Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee's Recommendation Backs Broader Access to Key Neuroprotective Peptides (GlobeNewswire) -6.36%
  • Firefly's AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD (GlobeNewswire)
  • With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World's First Known 200,000+ Standardized EEG/ERP Depository (GlobeNewswire) +6.00%
  • Firefly Confirms Public-Private Partnership with the Department of War (GlobeNewswire) +79.76%
  • Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD (GlobeNewswire) +58.05%
  • What's Going On With Firefly Neuroscience Stock On Friday? (Benzinga) +30.28%
  • Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion (PR Newswire) -8.39%
  • Firefly Neuroscience Skyrockets - Brain Scan Breakthrough Fuels Rally (Benzinga) +126.28%
  • Firefly Progresses Toward Development and Commercial Launch of its Foundation Model of the Human Brain Powered by NVIDIA GPU Acceleration (GlobeNewswire)
  • Firefly Neuroscience Reports Third Quarter 2025 Financial Results (GlobeNewswire) +5.45%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2022Q32022-11-21---7.671---
2022Q22022-08-15---2.634---
2022Q12022-05-23---3.605---
2021Q32021-11-03---0.227---
2021Q12021-05-18--0.6613.42--
2020Q42021-02-17--0.8883.10--
2020Q32020-11-16--0.5443.92--
2020Q22020-08-18---0.0934.82--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual0.6-0.137-1.921.029-2.699-30.111-0.805-1.598-1.971-0.4888
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.606-0.452-1.742-0.145-0.196-0.195-0.129-0.096-0.069
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual10.6418.93410.16513.90315.03411.0230.4980.1081.1422.06
Period201720182019202020212022202320242025TTM
Sales, quarterly0.0330.0530.0430.2990.3880.4120.4850.5140.647
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual0.3730.3730.3740.3750.5750.6393.6798.12213.96415.749
Period201720182019202020212022202320242025MRQ
Shares, quarterly8.4768.12211.67913.29913.47713.96414.86515.68415.749
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2.061.140.110.5011.0215.0313.9010.168.93
Cost of Goods Sold Incl. D&A0.930.500.075.588.3811.6211.698.776.79
Gross Profit1.130.650.042.402.643.412.211.402.14
Selling, General and Administrative Excl. Other9.069.259.223.587.175.291.802.132.21
Research and Development1.791.481.950.74-----
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-7.93-8.61-9.18-3.08-4.53-1.870.41-0.73-0.06
Interest Expense0.020.160.070.020.080.04-0.000.00
Unusual Expense0.1010.971.030.00-0.040.300.00--
Net Income Before Taxes-7.95-19.88-10.46-2.60-5.49-2.200.41-0.72-0.05
Income Taxes0.000.010.000.000.81-1.070.000.000.00
Consolidated Net Income-8.28-24.53-10.46-2.60-6.31-1.130.41-0.72-0.05
Net Income From Continuing Operations-8.28-24.53-10.46-2.60-6.31-1.130.41-0.72-0.05
Net Income-8.28-24.53-10.46-2.60-17.75-1.130.41-0.72-0.05
EPS (Recurring)-0.38-1.35-1.49-0.81-30.16-2.191.03-1.92-0.14
EPS (Basic, Before Extraordinaries)-0.49-1.97-1.60-0.81-30.11-2.701.10-1.92-0.14
EPS (Diluted)-0.49-1.97-1.60-0.81-30.11-2.701.03-1.92-0.14
EBITDA-7.74-8.43-9.11-3.08-4.13-1.640.42-0.72-0.05
Non-Operating Income (Expense)0.11-0.14-0.180.49-0.920.010.000.010.01
Other After Tax Adjustments-0.33-4.650.000.000.000.000.000.000.00
Stock Option Compensation Expense56.5256.01204.9323.301.011.360.030.010.03
Price To Sales Ratio16.039.53160.6432.920.774.141.260.150.18
Gross Margin54.8656.4837.96481.3423.9822.7115.8913.7723.99
Operating Margin-385.23-753.50-8,500.00-618.07-41.09-12.452.96-7.16-0.70
Net Margin-402.14-2,148.07-9,685.19-522.69-161.06-7.532.97-7.06-0.57
Shares Outstanding15.7513.968.123.680.640.570.380.370.37
Market Capitalization15.3215.3222.533.359.1885.341.461.461.46

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.650.510.480.410.390.300.040.05
Cost of Goods Sold Incl. D&A0.120.260.260.280.300.070.020.06
Gross Profit0.530.250.220.130.090.230.02-0.01
Selling, General and Administrative Excl. Other2.072.232.232.532.591.862.092.56
Research and Development0.380.530.420.460.380.340.310.44
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.54-1.97-2.01-2.40-2.50-1.63-2.06-2.56
Interest Expense0.000.010.010.010.010.010.130.03
Unusual Expense0.000.000.000.100.150.0010.721.03
Net Income Before Taxes-1.48-1.98-2.00-2.48-2.64-1.83-12.93-3.78
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-1.48-1.98-2.09-2.72-2.64-1.83-17.34-3.79
Net Income From Continuing Operations-1.48-1.98-2.09-2.72-2.64-1.83-17.34-3.79
Net Income-1.48-1.98-2.09-2.72-2.64-1.83-17.34-3.79
EPS (Recurring)-0.07-0.10-0.13-0.19-0.19-0.14-0.99-0.37
EPS (Basic, Before Extraordinaries)-0.07-0.10-0.13-0.19-0.20-0.14-1.74-0.45
EPS (Diluted)-0.07-0.10-0.13-0.19-0.20-0.14-1.74-0.45
EBITDA-1.49-1.93-1.97-2.35-2.45-1.59-2.05-2.50
Non-Operating Income (Expense)0.07-0.000.010.030.03-0.18-0.01-0.16
Other After Tax Adjustments0.000.00-0.09-0.240.000.00-4.410.00
Stock Option Compensation Expense0.240.270.4255.590.170.060.2512.72
Price To Sales Ratio16.0313.8422.3310.7050.1683.7719.255.68
Gross Margin81.1449.2245.5731.5522.6877.2655.81-11.32
Operating Margin-238.33-384.05-414.43-583.01-645.36-546.49-4,802.33-4,833.96
Net Margin-228.59-385.99-431.75-659.95-680.15-613.04-40,325.58-7,141.51
Shares Outstanding15.7515.6814.8713.9613.4813.3011.688.12
Market Capitalization15.3218.8830.9911.8138.9736.4031.7222.53

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments2.751.812.140.734.931.861.041.962.73
Short Term Receivables0.190.120.081.631.661.440.670.650.62
Inventories0.110.000.000.000.000.000.000.000.00
Other Current Assets0.980.700.030.290.120.050.050.100.07
Total Current Assets4.032.632.252.656.723.351.752.723.42
Net Property, Plant & Equipment0.150.140.000.480.780.110.160.010.01
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Long-Term Note Receivable----0.000.21---
Intangible Assets6.040.180.392.3115.63----
Deferred Tax Assets--0.230.691.07----
Other Assets0.271.660.002.550.230.100.460.300.31
Total Assets10.484.602.648.6824.433.772.373.023.73
Short Term Debt Incl. Current Port. of LT Debt0.000.690.000.630.190.140.100.000.00
Accounts Payable1.351.820.630.570.650.100.220.030.05
Income Tax Payable--0.000.00-----
Other Current Liabilities1.472.471.902.681.141.560.851.131.79
Total Current Liabilities2.824.982.533.891.981.801.171.151.84
Long Term Debt0.000.000.000.300.510.360.050.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities--0.240.752.23----
Other Liabilities0.020.000.000.002.270.000.000.000.00
Total Liabilities2.844.982.534.956.992.161.211.151.84
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity7.64-0.380.113.7317.441.611.161.871.89
Total Shareholders Equity7.64-0.380.113.7317.441.611.161.871.89
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity7.64-0.380.113.7317.441.611.161.871.89
Total Liabilities & Stockholders Equity10.484.602.648.6824.433.772.373.023.73
Book Value Per Share0.55-0.050.035.8430.354.303.115.025.07
Tangible Book Value Per Share0.11-0.07-0.082.233.144.303.115.025.07
Full-Time Employees171442535537242427
Price to Book Ratio1.151.041.160.734.890.670.670.670.67
Return on Assets-325.39-223.78-46.00-38.10-8.0213.45-26.58-1.516.58
Return on Equity-675.60-1,104.72-135.61-59.57-11.8829.78-47.27-2.7113.98
Return on Invested Capital-321.21--2,388.07-440.14-6.3020.98-59.38-2.7313.01
Quick Ratio1.390.530.890.683.391.861.502.361.86
Current Ratio1.430.530.890.683.391.861.502.361.86

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-3.54-19.88-10.46-2.60-17.75-1.130.41-0.72-0.05
Depreciation0.190.170.070.000.400.240.010.010.01
Other Funds (Non Cash)-2.6312.703.790.2914.480.350.030.010.03
Funds from Operations-5.98-7.01-6.60-2.31-5.89-0.550.45-0.71-0.01
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.66-1.180.450.14-0.12-0.19-0.03-0.21-0.75
Cash from Operating Activities-6.63-8.19-6.16-2.17-6.01-0.740.42-0.92-0.76
Capital Expenditures-0.20-0.13-0.41-0.39-0.54-0.07-0.06-0.01-0.01
Net Assets From Acquisitions0.00-2.360.000.000.00-9.510.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.00-0.060.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.20-2.49-0.48-0.39-0.54-9.58-0.06-0.01-0.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock8.009.094.344.641.9213.390.010.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock8.009.094.344.641.9213.390.010.000.00
Proceedsfrom Stock Options7.600.004.314.640.000.000.000.000.00
Issuance or Reduction of Debt, Net2.532.531.960.000.420.000.450.000.00
Change in Long Term Debt0.000.000.000.000.000.000.450.000.00
Issuance of Long Term Debt0.000.000.000.000.001.000.450.000.00
Reduction of Long Term Debt0.000.000.000.000.00-1.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities10.5311.626.304.642.3513.390.460.000.00
Net Change in Cash3.700.94-0.332.08-4.203.070.82-0.92-0.77
Free Cash Flow-6.83-8.32-6.30-2.17-6.55-0.800.36-0.93-0.77
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow------48.71--
Deferred Taxes & Investment Tax Credit-0.000.000.00-3.020.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments8.029.233.132.754.335.92
Short Term Receivables0.160.190.190.190.180.20
Inventories0.060.040.100.110.080.13
Other Current Assets0.800.771.040.980.841.28
Total Current Assets9.0410.224.464.035.437.53
Net Property, Plant & Equipment0.290.230.200.150.230.14
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets5.925.966.006.046.076.27
Other Assets0.200.350.250.270.671.00
Total Assets15.4516.7710.9110.4812.4114.94
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00
Accounts Payable0.990.881.331.351.341.50
Other Current Liabilities1.031.221.121.471.371.29
Total Current Liabilities2.022.102.452.822.722.79
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.010.010.020.030.04
Total Liabilities2.022.102.472.842.752.84
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity13.4314.668.447.649.6612.10
Total Shareholders Equity13.4314.668.447.649.6612.10
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity13.4314.668.447.649.6612.10
Total Liabilities & Stockholders Equity15.4516.7710.9110.4812.4114.94
Book Value Per Share0.850.930.570.550.720.91
Tangible Book Value Per Share0.480.550.160.110.270.44
Full-Time Employees---17--
Price to Book Ratio1.152.133.991.223.206.37
Return on Assets-59.42-59.52-79.79-325.39-288.94-298.63
Return on Equity-71.70-70.52-136.27-675.60-411.76-404.29
Return on Invested Capital-11.01-13.53-24.80-35.60-27.33-15.15
Quick Ratio4.454.851.781.391.972.65
Current Ratio4.484.871.821.432.002.69

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-1.48-1.98-2.001.93-7.05-1.83
Depreciation0.050.050.040.050.060.04
Other Funds (Non Cash)0.340.540.58-4.105.240.37
Funds from Operations-1.09-1.40-1.38-2.12-1.75-1.42
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.04-0.35-0.570.310.27-0.97
Cash from Operating Activities-1.13-1.75-1.95-1.80-1.49-2.39
Capital Expenditures-0.07-0.04-0.06-0.02-0.09-0.01
Net Assets From Acquisitions0.000.000.000.000.00-2.36
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.07-0.04-0.06-0.02-0.09-2.37
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.007.892.39-2.28-0.021.14
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.007.892.39-2.28-0.021.14
Proceedsfrom Stock Options0.007.892.24-2.53-0.031.14
Issuance or Reduction of Debt, Net0.000.000.002.530.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.007.892.390.25-0.021.14
Net Change in Cash-1.206.100.38-1.58-1.59-3.63
Free Cash Flow-1.20-1.79-2.01-1.83-1.57-2.40

Revenue breakdown

Product2025: 111.00K
Product and Service, Other2025: 33.00K
Rentals2024: 67.00K 2025: 74.00K
Service2024: 41.00K 2025: 814.00K
Subscription and Circulation2025: 110.00K
United States2024: 108.00K 2025: 1.14M
Total Services-Prepackaged Software revenue2024: 108.00K 2025: 1.14M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.89%0.6M14.2M2.64M
2026-10-155.28%0.8M14.2M2.64M
2026-09-307.71%1.1M14.2M2.65M
2026-09-152.11%0.3M14.2M117.30K
2026-08-313.06%0.4M13.8M188.64K
2026-08-143.46%0.5M13.8M211.37K
2026-07-314.36%0.6M13.7M231.93K
2026-07-154.90%0.7M13.4M427.05K
2026-06-305.24%0.7M13.4M611.90K
2026-06-155.59%0.7M13.4M3.04M
2026-05-295.57%0.7M13.3M10.39M
2026-05-156.88%0.9M13.3M10.37M
2026-04-308.58%1.0M11.9M10.49M
2026-04-1510.98%1.3M11.9M10.46M
2026-03-3111.08%1.3M12.0M10.30M
2026-03-1313.51%1.6M11.5M7.73M
2026-02-273.37%0.4M11.5M122.59K
2026-02-133.41%0.4M11.5M138.39K
2026-01-303.89%0.4M11.5M159.34K
2026-01-154.13%0.4M10.8M212.49K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-143Initial statement of beneficial ownership of securities2026-09-08SEC
2026-09-148-KCurrent report2026-09-08SEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-078-KCurrent report2026-08-05SEC
2026-07-09DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-08-05SEC
2026-07-02424B3SEC
2026-06-30EFFECTEffectiveness filing by commission orderSEC
2026-06-29PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-08-05SEC
2026-06-268-KCurrent report2026-06-25SEC
2026-06-23S-3/ASEC
2026-06-228-KCurrent report2026-06-18SEC
2026-05-20S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-05-20S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-128-KCurrent report2026-05-06SEC
2026-04-228-KCurrent report2026-04-16SEC
2026-04-16DNotice of sales of securities on Form D (Regulation D)SEC
2026-03-3110-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-133/A2024-08-12SEC
2026-03-128-KCurrent report2026-03-12SEC
2026-03-124Statement of changes in beneficial ownership of securities2026-03-10SEC
2026-03-124Statement of changes in beneficial ownership of securities2026-03-10SEC
2026-02-048-KCurrent report2026-02-03SEC
2026-02-03424B5SEC
2026-01-30SCHEDULE 13D/ASEC
2025-12-31SCHEDULE 13D/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Murchinson Ltd.4.17%
BlackRock, Inc.1.20%
BOOTHBAY FUND MANAGEMENT, LLC1.15%
GEODE CAPITAL MANAGEMENT, LLC0.77%
VANGUARD CAPITAL MANAGEMENT LLC0.72%
JANE STREET GROUP, LLC0.43%
VANGUARD FIDUCIARY TRUST CO0.33%
STATE STREET CORP0.30%
Cygnus Capital Advisors, LLC0.29%
NORTHERN TRUST CORP0.21%

Funds

Fund% owned
VANGUARD EXTENDED MARKET INDEX FUND0.72%
Fidelity Extended Market Index Fund0.38%
iShares Micro-Cap ETF0.31%
Fidelity Total Market Index Fund0.13%
Fidelity Series Total Market Index Fund0.10%
Fidelity Nasdaq Composite Index Fund0.02%
1290 VT Micro Cap Portfolio0.02%

OakChart. AIFF. Cached 15 minutes.

Some panels did not load: ratings, insider.